The treatment landscape for inherited and acquired bleeding disorders is evolving rapidly as advances in biotechnology and pharmaceutical research improve patient care across the globe. Conditions such as hemophilia and von Willebrand disease require lifelong management, creating sustained demand for innovative therapies that enhance clotting function while reducing treatment burden. These...